학술논문
Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis
Document Type
Article
Author
Source
In: Leukemia and Lymphoma . (Leukemia and Lymphoma, 2024, 65(3):346-352)
Subject
Language
English
ISSN
10292403
10428194
10428194